Company research / LITS

Lite Strategy, Inc. (LITS)

CIK 0001262104 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Jun 30

Key ratios (year ended 2026-06-30)

-170.9%
Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 10-K (annual report) · 2026-09-28

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Stock splits: 1-for-20, first reflected in a filing dated 2023-05-11. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Period ended2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-30
Revenuen/a$0$65.30M$48.82M$40.70M$34.80M$27.76M$4.92M$1.62M$23.25M
Cost of Revenuen/an/an/an/a$0$1.41M$2.67M$4.26M$3.38M$5.00M
Gross Profit (computed)n/an/an/an/an/an/a$25.09M$652.0K-$1.76M$18.25M
R&D Expense$122.0K$3.92M$16.56M$52.45M$85.64M$69.40M$34.06M$32.30M$17.04M$7.24M
Operating Income-$66.58M-$17.45M$14.54M-$36.76M-$75.48M-$60.42M-$25.70M-$46.24M-$28.59M$2.38M
Depreciation & Amortization$0$368.0K$383.0K$386.0K$326.0K$285.0K$109.0K$80.0K$53.0K$85.0K
EBITDA-$66.58M-$17.09M$14.93M-$36.38M-$75.16M-$60.14M-$25.59M-$46.16M-$28.53M$2.47M
Net Income-$71.15M-$15.95M$18.00M-$32.00M-$54.00M-$41.00M-$47.17M-$16.82M-$40.07M$2.67M
EPS (Diluted)-$2.06-$2.39$2.67-$4.78-$9.99-$0.60-$0.52-$0.75-$0.97$0.07
Total Assets$42.69M$18.29M$41.38M$120.81M$177.84M$174.10M$209.73M$82.66M$104.66M$55.70M
Total Liabilities$1.07M$1.35M$8.36M$96.19M$125.43M$124.63M$132.67M$34.73M$54.20M$4.87M
Shareholders' Equity$41.62M$16.93M$33.02M$24.62M$52.41M$49.47M$77.06M$47.93M$50.46M$50.84M
Cash & Equivalents$5.71M$18.01M$3.71M$16.91M$15.74M$8.54M$12.33M$9.59M$13.31M$8.46M
Operating Cash Flow-$9.12M-$20.84M-$50.47M-$52.48M-$48.75M-$31.96M$34.26M-$29.42M-$21.04M$3.49M
Capital Expendituresn/a$0$7.0K$35.0K$479.0K$708.0K$894.0K$217.0Kn/a$51.0K
Free Cash Flown/a-$20.84M-$50.48M-$52.52M-$49.23M-$32.67M$33.36M-$29.64Mn/a$3.44M
Share Repurchases$4.89M$0n/an/an/an/an/an/an/an/a
Dividends Paidn/a$0$11.66M$0n/an/an/an/an/an/a
Shares Outstanding32.41M6.66M6.66M6.66M6.66M112.61M111.51M73.55M70.41M36.77M
Dividends Per Sharen/an/a$1.75n/an/an/an/an/an/an/a
Weighted Average Diluted Shares34.56M6.66M6.66M6.66M6.26M114.48M91.08M72.39M41.43M36.94M
EPS (Basic)-$2.06-$2.39$2.67-$4.78-$8.75-$0.37-$0.52-$0.24-$0.97$0.07

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView